Histological and proteomic analysis of reversible H-RasV12G expression in transgenic mouse skin

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2244-2252

  Oh, Won Jun ^a   Rishi, Vikas ^a   Pelech, Steven ^b   Vinson, Charles ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; APOPTOSIS INDUCING FACTOR; CASPASE 12; CASPASE 3; CASPASE 5; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FAS LIGAND; GAMMA ADDUCIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME ALPHA; KERATIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NUCLEOPHOSMIN; PHOSPHOPROTEIN; PROTEIN BAX; PROTEIN KINASE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C EPSILON; RAF PROTEIN; RAS PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL CELL; CANCER REGRESSION; CELL DIVISION; CELL HYPERPLASIA; CONTROLLED STUDY; EPIDERMIS CELL; GENE EXPRESSION REGULATION; GENE TARGETING; HAIR FOLLICLE; HISTOPATHOLOGY; IMMUNOBLOTTING; KERATINOCYTE; MOLECULAR GENETICS; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SKIN CANCER; SKIN CYST; STROMA CELL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; APOPTOSIS; CELL DIVISION; DNA PRIMERS; GENES, RAS; MICE; MICE, TRANSGENIC; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PROTEIN KINASES; PROTEOME; SKIN; SKIN PHYSIOLOGY;

EID: 35148825941     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm127     Document Type: Article

References (49)

1. Malumbres,X. et al. (2003) RAS oncogenes: The first 30 years. Nat. Rev. Cancer 3, 459-465.
2. Nikiforova,M.N. et al. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: Evidence for distinct molecular pathways in thyroid follicular carcinoma. J. C1in. Endocrinol. Metab. 88, 2318-2326.
3. Sekiya,T. et al. (1984) Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene aqtivated in a melanoma from a Japanese patient. Proc. Natl Acad. Sci. USA, 81, 4771-4775.
4. Aoki,Y. et al. (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet., 37, 1038-1040.
5. Vitale-Crosa. et al. (2OO4) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res., 64, 8804-8807.
6. Bailleul,B. et al. (1990) Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62, 697-708.
7. Bos,J.L. (1989) Ras oncogenes in human cancer: A review. Cancer Res. 49, 4682-4689.
8. Yuspa,S.H. (1994) The pathogenesis of squamous cell cancer lessons learned from studies of skin carcinogenesis - thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res., 54, 1179-1189.
9. Marshall,M.S. (1995) Ras target proteins in eukaryotic cells. FASEB J 9, 1311-1318.
10. Shuman,J.D. et al. (2004) Cell cycle-dependent phosphorylation of C/EBP-beta mediates oncogenic cooperativity between C/EBPbetaand H-RasV12. Mol. Cell. Biol., 24,7380-7391.
11. l McFall,A. et al. (2001) Oncogenic ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol. Cell. Biol., 21, 5488-5499.
12. Aplin A.E. et al. (1999) Anchorage-dependent regulation of the mitogen activated protein kinase cascade by growth factors is supported by a variety of integrin alpha chains. J. Biol. Chem., 274, 31223-31228.
13. Eckert,L.B. et al. (2004) Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res., 64, 4585-4592.
14. Shields,J.M. et al. (2000) Understanding Ras: 'it ain't over 'til it's over. Trends Cell Biol., 10, 147-154.
15. Yuspa, S.H. et al. (1994) Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J. Investig. Dermatol., 103 90S-95S.
16. Roper,E. et al. (2001) p19ARF-independent induction of p53 and ce4 cycle arrest by Raf in murine keratinocytes. EMBO Rep., 2, 145-150.
17. Chin,L. et al. (1999) Essential role for oncogenic Ras in tumour maintenance. Nature, 400, 468-472.
18. Felsher,D.W. et al. (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell, 4, 199-207.
19. Politi,K. et al. (2006) Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev. 20, 1496-1510.
20. Weinstein I.B. (2002) Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science, 297, 63-64.
21. Varmus,H. (2006) The newera in cancer research. Science, 312 1162-1165.
22. Diamond, I. et al. (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J. Investig. Dermatol., 115, 788-794.
23. Dlugosz,A.A. et al. (1995) Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol., 254, 3-20.
24. Nunez,N.R et al. (2006) Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res., 66 5469-5476.
25. Pelech,S. et al. (2003) Kinetworks protein kinase multiblot analysis. Methods Mol. Biol., 218, 99-111.
26. Raimondi,A.R. et al. (2006) Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter. Am J. Pathol., 168, 1654-1665.
27. Okada,F. et al. (1998) Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/ vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. Natl Acad. Sci. USA, 95, 3609-3614.
28. Felsher,D.W. (2004) Reversibility of oncogene-induced cancer. Curr Opin. Genet. Dev., 14, 37-42.
29. Young,T. et-al. (2005) Proteomics analysis of H-RAS-mediated oncogenic transformation in it genetically defined human ovarian cancer model. Oncogene, 24, 6174-6184.
30. Cregan,S.P. et al. (2002) Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol., 158, 507-517.
31. Maruoka,Y. et al. (1997) Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem. Biophys. Res. Commun. 238, 886-890.
32. Downward, J. (1998) Ras signalling and apoptosis. Curr. Opin. Genet. Dev., 8, 49-54.
33. Song,K.S. et al. (2003) Induction of MUC8 gene expression by interleukin-1 beta is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells. J. Biol. Chem., 278, 34890-34896.
34. Fisher,G.H. et al. (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev., 15, 3249-3262.
35. Raj,D. et al. (2006) Keratinocyte apoptosis in epidermal development and disease. J. Investig: Dermatol., 126, 243-257.
36. Shachaf,C.M. et al. (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112-1117.
37. Mao,J.H. et al. (2004) Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev., 18, 1800-1805.
38. Thannickal,V.J. et al. (2003) Myofibroblast differentiation by transforming growth factor-betal is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem, 278, 12384-12389.
39. Fujio,Y. et al. (1999) Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem, 274, 16349-16354.
40. Shimizu,H. et al. (1999) Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J. Investig. Dermatol., 112, 769-774.
41. Kawai,T. et al. (2003) ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. Mol. Cell. Biol., 23, 6174-6186.
42. Okuda,H. et al. (1999) Protein kinase Calpha promotes apoptotic cell death in gastric cancer cells depending upon loss of anchorage. Oncogene, 18, 5604-5609.
43. Cataisson,C. et al. (2003) Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways. J. Immunol., 171, 2703-2713.
44. Guillem,J.G. et al. (1988) Changes in expression of oncogenes and endogenous retroviral-like sequences during colon carcinogenesis. Cancer Res., 48, 3964-3971.
45. Colapietro,A.M. et al. (1993) Characterization of benzo[a]pyrene-initiated mouse slan papillomas for Ha-ras mutations and protein kinase C levels. Carcinogenesis, 14, 2289-2295.
46. Weyman,C.M. et al. (1988) Partial down-regulation of protein kinase C in C3H l0T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. Cancer Res., 48, 6535-6541.
47. Haliotis,T. et al. (1990) Expression of ras oncogene leads to down-regulation of protein kinase C. Int. J. Cancer 45, 1177-1183.
48. Wolfman,A. et al. (1987) Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature, 325, 359-361.
49. Imamdi,R. et al. (2004) Protein kinase C mediates cisplatin-induced loss of adherens junctions followed by apoptosis of renal proximal tubular epithelial cells. J. Pharmacol. Exp. Ther., 311, 892-903.